(Total Views: 489)
Posted On: 11/13/2020 1:55:47 PM
Post# of 70

$DRRX News Article - DURECT Corporation Announces Additional Safety Data and Efficacy Signals from Phase 1b Clinical Trial of DUR-928 in NASH Patients at The Liver Meeting Digital Experience(TM) 2020 https://marketwirenews.com/news-releases/dure...31832.html


My Twitter: WhyteStocks